|
A united states (ous) customer contacted the siemens healthcare diagnostics remote services center (rsc) and reported observation of an elevated advia centaur total hcg (thcg) result which was discordant relative to repeat testing.The assay¿s instructions for use (ifu) states the following, under interpretation of results: ¿results of this assay should always be interpreted in conjunction with the patient¿s medical history, clinical presentation, and other findings.¿ siemens is evaluating the event.
|
|
Siemens filed initial mdr 1219913-2025-00032 on 04-feb-2025.Additional information (06-mar-2025): siemens healthcare diagnostics has concluded the investigation of the event.Siemens evaluated the instrument data, and the information provided by the customer.A siemens customer service engineer (cse) was dispatched to the customer¿s site.During the visit, the cse decontaminated the system, replaced the wash separation manifold, acid and base pumps, reagent probes 1 and 2, luminometer, vacuum regulator and waste reservoir bottle tubing/cap.Advia centaur xp thcg assay performance was monitored following these service actions and it remains acceptable.Siemens further evaluated the event and concluded that the issue with vacuum which was resolved by replacing the vacuum regulator and performing service actions, potentially contributed to the elevated thcg result.The reagent and instrument are performing according to specifications.The customer is operational, and no further actions are required.Note: in section h6, codes for investigation findings and investigation conclusions have been updated.
|